Welcure Drugs [WELCURE] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Welcure Drugs

BSE
Loading...

Sun Pharmaceutical

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Welcure Drugs wins in 6 metrics, Sun Pharmaceutical wins in 13 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricWelcure DrugsSun PharmaceuticalBetter
P/E Ratio (TTM)2.2437.73Welcure Drugs
Price-to-Book Ratio0.455.42Welcure Drugs
Debt-to-Equity Ratio120.183.26Sun Pharmaceutical
PEG Ratio0.00-1.94Sun Pharmaceutical
EV/EBITDA5.5723.98Welcure Drugs
Profit Margin (TTM)7.96%19.29%Sun Pharmaceutical
Operating Margin (TTM)10.38%24.34%Sun Pharmaceutical
EBITDA Margin (TTM)10.38%24.34%Sun Pharmaceutical
Return on Equity2.12%15.08%Sun Pharmaceutical
Return on Assets (TTM)0.81%11.87%Sun Pharmaceutical
Free Cash Flow (TTM)$-2.22B$119.44BSun Pharmaceutical
Dividend YieldN/A1.26%N/A
1-Year Return-13.65%-13.08%Sun Pharmaceutical
Price-to-Sales Ratio (TTM)0.217.28Welcure Drugs
Enterprise Value$1.91B$3,678.87BSun Pharmaceutical
EV/Revenue Ratio0.596.84Welcure Drugs
Gross Profit Margin (TTM)10.40%79.58%Sun Pharmaceutical
Revenue per Share (TTM)$38$224Sun Pharmaceutical
Earnings per Share (Diluted)$2.69$43.23Sun Pharmaceutical
Beta (Stock Volatility)-2.070.28Welcure Drugs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Welcure Drugs vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Welcure Drugs
Sun Pharmaceutical
Welcure Drugs Stock Overview | Sun Pharmaceutical Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Welcure Drugs4.97%20.73%-33.73%-43.59%-19.42%-40.13%
Sun Pharmaceutical-1.30%3.69%4.56%-1.60%-0.80%-12.53%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Welcure Drugs-13.65%-18.73%225.49%196.43%109.46%-49.31%
Sun Pharmaceutical-13.08%69.32%239.52%85.64%710.50%2,595.42%

News Based Sentiment: Welcure Drugs vs Sun Pharmaceutical

Welcure Drugs

News based Sentiment: MIXED

October was a pivotal month for Welcure Drugs, marked by a potential acquisition offer and significant financial growth, but also continued stock volatility and regulatory scrutiny. The mixed signals create a complex investment picture, making it a significant month for the company's trajectory.

View Welcure Drugs News Sentiment Analysis

Sun Pharmaceutical

News based Sentiment: MIXED

October was a month of significant contrasts for Sun Pharma. While the company demonstrated revenue growth and made strategic acquisitions, the imposition of a 100% US tariff on Indian pharmaceuticals presents a major headwind. This combination of positive and negative developments creates a mixed investment outlook.

View Sun Pharmaceutical News Sentiment Analysis

Performance & Financial Health Analysis: Welcure Drugs vs Sun Pharmaceutical

MetricWELCURESUNPHARMA
Market Information
Market Cap i₹712.18M₹4.01T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i8,204,9943,168,435
90 Day Avg. Volume i6,251,9262,778,768
Last Close₹6.97₹1,631.60
52 Week Range₹5.26 - ₹15.89₹1,548.00 - ₹1,947.00
% from 52W High-56.14%-16.20%
All-Time High₹25.00 (Sep 19, 2005)₹1,960.35 (Sep 30, 2024)
% from All-Time High-72.12%-16.77%
Growth Metrics
Quarterly Revenue Growth-34.93%0.10%
Quarterly Earnings GrowthN/A-0.20%
Financial Health
Profit Margin (TTM) i0.08%0.19%
Operating Margin (TTM) i0.10%0.24%
Return on Equity (TTM) i0.02%0.15%
Debt to Equity (MRQ) i120.183.26
Cash & Liquidity
Book Value per Share (MRQ)₹13.32₹300.99
Cash per Share (MRQ)₹0.01₹108.88
Operating Cash Flow (TTM) i₹-2,249,340,000₹110.84B
Levered Free Cash Flow (TTM) i₹21.70M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A1.26%
Last 12-Month Dividend iN/A₹21.00

Valuation & Enterprise Metrics Analysis: Welcure Drugs vs Sun Pharmaceutical

MetricWELCURESUNPHARMA
Price Ratios
P/E Ratio (TTM) i2.2437.73
Forward P/E iN/A49.91
PEG Ratio i0.00-1.94
Price to Sales (TTM) i0.217.28
Price to Book (MRQ) i0.455.42
Market Capitalization
Market Capitalization i₹712.18M₹4.01T
Enterprise Value i₹1.91B₹3.68T
Enterprise Value Metrics
Enterprise to Revenue i0.596.84
Enterprise to EBITDA i5.5723.98
Risk & Other Metrics
Beta i-2.070.28
Book Value per Share (MRQ) i₹13.32₹300.99

Financial Statements Comparison: Welcure Drugs vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)WELCURESUNPHARMA
Revenue/Sales i₹3.00B₹137.86B
Cost of Goods Sold i₹2.69B₹28.15B
Gross Profit i₹311.96M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹311.36M₹33.72B
EBITDA i₹311.41M₹47.66B
Pre-Tax Income i₹311.36M₹31.73B
Income Tax i₹78.37M₹8.70B
Net Income (Profit) i₹232.99M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)WELCURESUNPHARMA
Cash & Equivalents i₹1.28M₹102.69B
Total Current Assets i₹1.82B₹526.24B
Total Current Liabilities i₹412.69M₹181.94B
Long-Term Debt i₹1.23B₹3.58B
Total Shareholders Equity i₹1.03B₹724.86B
Retained Earnings i₹-100.79M₹578.62B
Property, Plant & Equipment iN/A₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)WELCURESUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricWELCURESUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i8,204,9943,168,435
Average Daily Volume (90 Day) i6,251,9262,778,768
Shares Outstanding i112.51M2.40B
Float Shares i14.84M1.06B
% Held by Insiders i0.85%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Welcure Drugs vs Sun Pharmaceutical

MetricWELCURESUNPHARMA
Last 12-Month Dividend iN/A₹21.00
Last 12-Month Dividend Yield iN/A1.26%
3-Year Avg Annual Dividend iN/A₹14.67
3-Year Avg Dividend Yield iN/A0.46%
3-Year Total Dividends iN/A₹44.00
Ex-Dividend DateN/AJul 07, 2025